366 related articles for article (PubMed ID: 33272326)
1. The pleiotropic role of p53 in functional/dysfunctional neurons: focus on pathogenesis and diagnosis of Alzheimer's disease.
Abate G; Frisoni GB; Bourdon JC; Piccirella S; Memo M; Uberti D
Alzheimers Res Ther; 2020 Dec; 12(1):160. PubMed ID: 33272326
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
3. A Conformational Variant of p53 (U-p53AZ) as Blood-Based Biomarker for the Prediction of the Onset of Symptomatic Alzheimer's Disease.
Piccirella S; Van Neste L; Fowler C; Masters CL; Fripp J; Doecke JD; Xiong C; Uberti D; Kinnon P
J Prev Alzheimers Dis; 2022; 9(3):469-479. PubMed ID: 35841248
[TBL] [Abstract][Full Text] [Related]
4. Circulatory GSK-3β: Blood-Based Biomarker and Therapeutic Target for Alzheimer's Disease.
Kumari S; Singh A; Singh AK; Yadav Y; Bajpai S; Kumar P; Upadhyay AD; Shekhar S; Dwivedi S; Dey AB; Dey S
J Alzheimers Dis; 2022; 85(1):249-260. PubMed ID: 34776454
[TBL] [Abstract][Full Text] [Related]
5. OCIAD1 contributes to neurodegeneration in Alzheimer's disease by inducing mitochondria dysfunction, neuronal vulnerability and synaptic damages.
Li X; Wang L; Cykowski M; He T; Liu T; Chakranarayan J; Rivera A; Zhao H; Powell S; Xia W; Wong STC
EBioMedicine; 2020 Jan; 51():102569. PubMed ID: 31931285
[TBL] [Abstract][Full Text] [Related]
6. Unfolded p53 in the pathogenesis of Alzheimer's disease: is HIPK2 the link?
Stanga S; Lanni C; Govoni S; Uberti D; D'Orazi G; Racchi M
Aging (Albany NY); 2010 Sep; 2(9):545-54. PubMed ID: 20876941
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-ß promotes neurotoxicity by Cdk5-induced p53 stabilization.
Lapresa R; Agulla J; Sánchez-Morán I; Zamarreño R; Prieto E; Bolaños JP; Almeida A
Neuropharmacology; 2019 Mar; 146():19-27. PubMed ID: 30452955
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics and pharmagenomics, trends in normal and pathological aging studies: focus on p53.
Lanni C; Racchi M; Uberti D; Mazzini G; Stanga S; Sinforiani E; Memo M; Govoni S
Curr Pharm Des; 2008; 14(26):2665-71. PubMed ID: 18991686
[TBL] [Abstract][Full Text] [Related]
9. [Evolution of the diagnostic frontiers of Alzheimer's disease and new therapeutic possibilities].
Gavrilova SI
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11. Vyp. 2):38-44. PubMed ID: 36412155
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
Podhorna J; Krahnke T; Shear M; Harrison JE;
Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Extracellular and Intracellular Blood Compartments Highlights Redox Alterations in Alzheimer's and Mild Cognitive Impairment Patients.
Arce-Varas N; Abate G; Prandelli C; Martínez C; Cuetos F; Menéndez M; Marziano M; Cabrera-García D; Fernández-Sánchez MT; Novelli A; Memo M; Uberti D
Curr Alzheimer Res; 2017; 14(1):112-122. PubMed ID: 27748187
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer's Disease.
Villa C; Stoccoro A
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893045
[TBL] [Abstract][Full Text] [Related]
13. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Shen L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2013 Sep; 9(5):e111-94. PubMed ID: 23932184
[TBL] [Abstract][Full Text] [Related]
14. The regulation of p53 up-regulated modulator of apoptosis by JNK/c-Jun pathway in β-amyloid-induced neuron death.
Akhter R; Sanphui P; Das H; Saha P; Biswas SC
J Neurochem; 2015 Sep; 134(6):1091-103. PubMed ID: 25891762
[TBL] [Abstract][Full Text] [Related]
15. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.
Ohyagi Y; Asahara H; Chui DH; Tsuruta Y; Sakae N; Miyoshi K; Yamada T; Kikuchi H; Taniwaki T; Murai H; Ikezoe K; Furuya H; Kawarabayashi T; Shoji M; Checler F; Iwaki T; Makifuchi T; Takeda K; Kira J; Tabira T
FASEB J; 2005 Feb; 19(2):255-7. PubMed ID: 15548589
[TBL] [Abstract][Full Text] [Related]
16. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease.
Cenini G; Sultana R; Memo M; Butterfield DA
J Cell Mol Med; 2008 Jun; 12(3):987-94. PubMed ID: 18494939
[TBL] [Abstract][Full Text] [Related]
18. The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease.
Jazvinšćak Jembrek M; Slade N; Hof PR; Šimić G
Prog Neurobiol; 2018 Sep; 168():104-127. PubMed ID: 29733887
[TBL] [Abstract][Full Text] [Related]
19. Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain.
Henderson BW; Gentry EG; Rush T; Troncoso JC; Thambisetty M; Montine TJ; Herskowitz JH
J Neurochem; 2016 Aug; 138(4):525-31. PubMed ID: 27246255
[TBL] [Abstract][Full Text] [Related]
20. Searching for predictive blood biomarkers: misfolded p53 in mild cognitive impairment.
Stanga S; Lanni C; Sinforiani E; Mazzini G; Racchi M
Curr Alzheimer Res; 2012 Dec; 9(10):1191-7. PubMed ID: 22746246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]